Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company

Napp Pharmaceuticals Limited

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is Napp Pharmaceuticals Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 18

  1. Allison Hogg 2024-2025 Director View profile
  2. Ake Gunnar Wikstrom 2018-2019 Director View profile
  3. Stuart David Baker 2017-2019 Director View profile
  4. Hywel Rhys Day 2017-2024 Director View profile
  5. Alberto MartÍNez 2014-2016 Director View profile
  6. David Alan Silver 2012-2019 Director View profile
  7. Dietmar Leitner 2011-2014 Director View profile
  8. Sara Elizabeth Shiels 2011-2012 Director View profile
  9. Robert Alan Clarke 2008-2012 Director View profile
  10. Antony Charles Mattessich 2005-2017 Director View profile
  11. Dr Julian Paul Schofield 2004-2019 Director View profile
  12. Dr Kenneth Lawrie Williamson 2003-2009 Director View profile
  13. Michael John Healey 2003-2005 Director View profile
  14. Michael Howard Lynch 2003-2012 Director View profile
  15. John Robert Brogden 1999-2005 Director View profile
  16. Christopher Benbow Mitchell 1998-2018 Director View profile
  17. Tiercel Services Limited 2009-2018 Corporate-secretary View profile
  18. Cornhill Services Limited 2008-2009 Corporate-secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

Public contracts won

4 contracts

From Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.

  • NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies. Buyer: The NHS Commissioning Board (operating under the name of NHS England) Value not published Date not published CPV 33600000 Source: Find a Tender

    CM/PHR/20/5591/01 - Midlands and East, Branded Medicines – Tranche B. Period of framework: 1 March 2021 to 28 February 2023 with an option to extend (at the Authority’s discretion) for a period or periods up to a total of 24 monthsCM/PHR/20…

    Framework
  • Oncology Generics Medicines Buyer: The Common Services Agency (more commonly known as NHS National Services Scotland) ("the Authority") Value not published Date not published CPV 33600000 Source: Find a Tender

    This Framework Agreement is for the supply of Oncology Generic medicines to NHS Scotland. The Goods have been separated into thirty-nine (39) categories, each of which is identified as a “Lot”. Full details of each Lot is contained in secti…

    Framework
  • NHS National Branded Interim - 1 June 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

    Provision of an NHS National Branded Interim - 1 June 2026 01/06/2026 - 30/04/2028 23 Months with an option or options to extend at the discretion of the authority up to a maximum of 25 months

    Framework
  • NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026 Buyer: NHS England Value not published Date not published Source: Find a Tender

    NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion f…

    Framework

About

Incorporated
22/12/1998

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Napp Pharmaceuticals Limited is controlled by Napp Pharmaceutical Holdings Limited
    Evidence
    active 75-100% shares · notified 2016-04-06 · source: Companies House PSC register
  2. Napp Pharmaceutical Holdings Limited is controlled by Stuart David Baker
    Evidence
    ceased 25-50% shares · notified 2016-04-06, ceased 2018-12-20 · source: Companies House PSC register

Ultimately controlled by Stuart David Baker.

7 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

15.5y median 15.5y
average tenure
23.5y
longest tenure

Directors past 6 years

First-time vs portfolio directors

Portfolio (2)

1
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 10Retail and trade 8Manufacturing 6Business services 2Finance 2Tech and media 2Dormant 1

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Gaps to watch

  • Several long-serving directors could step down together

Where to look Suggested search: succession planning for long-tenured seats.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
03690299
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data